August 10, 2009
American Academy of Pediatric Dentistry
Guideline on antibiotic prophylaxis for dental patients at risk for infection. This updates a previously published guideline summary.
Guideline on behavior guidance for the pediatric dental patient. This updates a previously published guideline summary.
Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. This updates a previously published guideline summary.
Guideline on fluoride therapy. This updates a previously published guideline summary.
Guideline on management of dental patients with special health care needs. This updates a previously published guideline summary.
Guideline on oral health care/dental management of heritable dental developmental anomalies.
Guideline on pediatric restorative dentistry. This updates a previously published guideline summary.
Society of Obstetricians and Gynaecologists of Canada
Clinical manifestations and diagnosis of HPV-related disease. In: Canadian consensus guidelines on human papillomavirus.
Cost-benefit analysis of HPV vaccination. In: Canadian consensus guidelines on human papillomavirus.
Counselling. In: Canadian consensus guidelines on human papillomavirus.
Prevention. In: Canadian consensus guidelines on human papillomavirus.
Screening for cervical cancer. In: Canadian consensus guidelines on human papillomavirus.
The role of HPV testing. In: Canadian consensus guidelines on human papillomavirus.
Treatment of external genital warts and pre-invasive neoplasia of the lower tract. In: Canadian consensus guidelines on human papillomavirus.
Newly Submitted
AASLD has submitted the following updated guidelines:
- Management of adult patients with ascites due to cirrhosis
- Primary biliary cirrhosis
To view a list of other guidelines in the NGC work queue, please visit our
Guidelines In Progress page.
Health Awareness Topics - August 2009
H1N1 Flu
Visit the
CDC Web site for the latest information on H1N1 flu.
How to Participate
- Submit guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
- Suggest a guideline for possible inclusion: Submit your suggestions for evidence-based guidelines that you would like to see included in NGC.
- Suggest a Guideline Synthesis topic: We welcome your suggestions for guideline synthesis topics!
Conference News
- AHRQ's 2009 Annual Conference "Research to Reform: Achieving Health System Change" is September 13-16 in Bethesda, MD. Learn about AHRQ's latest research aimed at quality and safety, delivery of services, and improving Americans' health status from leading health care research and policy experts. Register now.
- The 6th annual Guidelines International Network (G-I-N) conference, will be held November 1-4, 2009 in Lisbon, Portugal. Register online now. G-I-N conferences aim to bring together many colleagues from all over the world to develop collaborations with people from a wide range of organizations, through workshops, discussion, networking and informal sessions. The theme of the conference is "Evidence Translation in Different Countries." For further information and details, please visit the G-I-N Conference Web site.
Healthy People 2010
See NGC's
Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the
Healthy People 2010 focus areas, as well as other public health and patient safety topics.
Recent U.S. Food and Drug Administration (FDA) Advisory
- August 4, 2009: Tumor Necrosis Factor (TNF) Blockers: FDA has completed its analysis of tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other cancers associated with the use of these drugs in children and adolescents. This new safety information is now being added to the Boxed Warning for these products.
- August 3, 2009: Botox and Botox Cosmetic and Myobloc: Changes to the established drug names to reinforce individual potencies and prevent medication errors, and provided recommendations for healthcare professionals to consider, plus information for patients, family members, and caregivers.
- July 30, 2009: Colchicine (marketed as Colcrys): FDA has included important safety considerations in the approved prescribing information to assure safe use of Colcrys and is providing background information, a data summary and recommendations.
NGC's Sister Resources
Find Innovations and
QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's
Health Care Innovations Exchange Web site.
Look for Quality Measures in AHRQ's
National Quality Measures Clearinghouse (NQMC).
Other Resources
To locate a previous issue of "What's New This Week," go to the
What's New Archive.
Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to:
info@guideline.gov.
Submit your guidelines for inclusion in the National Guideline Clearinghouse!
Subscriptions
To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the
Subscription Management page.
